Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02114164
Other study ID # OH1-13-00489
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2016
Est. completion date July 15, 2019

Study information

Verified date October 2021
Source OhioHealth
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The AirSeal® System will allow for lower carbon dioxide (CO2) absorption rates than the standard Endopath System.


Description:

The primary observation to be made is the level of carbon dioxide in the arterial blood, specifically when the patient is insufflated and deflated during the surgery. As a result of the consistent pressure that the AirSealĀ® system maintains, carbon dioxide will be absorbed in lower levels when compared to the standard of care systems in which fluctuations in intra-peritoneum pressure are seen.


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date July 15, 2019
Est. primary completion date May 3, 2018
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age>18 - Eligible and elect to undergo robotic prostatectomy surgery @ OhioHealth Dublin Methodist Hospital Exclusion Criteria: - Age < 18 - Emergency surgery - Ascites - BMI>44 or <18

Study Design


Related Conditions & MeSH terms


Intervention

Device:
AirSeal System
To analyze the results of patients randomized to either the AirSeal system or Standard Endopath trocar.
Standard Endopath
This group receives the Standard Endopath Trocar for intraoperative insufflation.

Locations

Country Name City State
United States Dublin Methodist Hospital Columbus Ohio

Sponsors (2)

Lead Sponsor Collaborator
OhioHealth SurgiQuest, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intraoperative Pneumoperitoneal Pressure (mmHg) Pneumoperitoneal pressure is the pressure exerted by air or gas in the abdominal (peritoneal) cavity. As the amount of air/gas increases, the pressure (mmHg) increases. The highest pressure that occurred during the procedure was compared between groups. Through end of procedure, an average of 156 minutes
Secondary Intraoperative Arterial Blood Gas Carbon Dioxide (mmHg). The amount of dissolved carbon dioxide (PaCO2) in arterial blood (mmHg) during the operative procedure Baseline, 60 minutes, and at end of procedure, an average of 156 minutes
Secondary End-tidal Carbon Dioxide Pressure (mmHg) End-tidal carbon dioxide pressure is the partial pressure of carbon dioxide at the end of exhalation. Normal value is 35-45 mmHg. Baseline, 60 minutes, and at end of procedure, an average of 156 minutes
Secondary Carbon Dioxide Elimination (mmHg) Carbon dioxide elimination was calculated using end-tidal carbon dioxide pressure (EtCO2), tidal volume, respiratory rate, barometric pressure (pB = 760mm Hg), partial pressure of water vapor (PH2O = 13 mm Hg), and patient weight (kg) Baseline, 60 minutes, and at end of procedure, an average of 156 minutes
Secondary Intraoperative Arterial Blood Gas Oxygen (mmHg). The amount of dissolved oxygen (PaO2) in arterial blood (mmHg). Baseline, 60 minutes, and end of procedure, an average of 156 minutes
Secondary Number of Ventilator Interventions The number of times the anesthesiologist had to adjust ventilator settings Through end of procedure, an average of 156 minutes
Secondary Procedure Time (Minutes) The duration of the procedure Through end of procedure, an average of 156 minutes
Secondary Smoke Evacuation Quality Smoke evacuation quality throughout the procedure was assessed by the surgeon as below average, average, or above average Through end of procedure, an average of 156 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A